Nuwellis announces pricing of $2.7 million public offering

Minneapolis, april 26, 2024 (globe newswire) -- nuwellis, inc. (nasdaq: nuwe) (“nuwellis” or the “company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the pricing of a public offering of 11,250,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 16,875,000 shares of its common stock at a combined public offering price $0.24 per share (or pre-funded warrant in lieu thereof) and associated warrant. each share of common stock (or prefunded warrant in lieu thereof) is being sold together with one warrant to purchase one and a half shares of common stock. the warrants will have an exercise price of $0.40 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance.
NUWE Ratings Summary
NUWE Quant Ranking